FONTEYNE PAUL R.
Insider CIK 1727550 · APLS Director · AMLX Director · TORC Director · APMD Director · CVET Director · GLS Director · AMAG Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APMD Apnimed, Inc. | A Award deriv | 2026-08-03 | 2026-08-03 | 44,477 | — | $0 | 44,477 | SEC↗ |
| APMD Apnimed, Inc. | A Award deriv | 2026-08-03 | 2026-08-03 | 44,477 | — | $0 | 44,477 | SEC↗ |
| APMD Apnimed, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-03 | 44,477 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-03 | 44,477 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | A Award deriv | 2026-08-03 | 2026-08-03 | 51,890 | — | $0 | 51,890 | SEC↗ |
| APMD Apnimed, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-03 | 51,890 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | A Award deriv | 2026-08-03 | 2026-08-03 | 44,477 | — | $0 | 44,477 | SEC↗ |
| APMD Apnimed, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-03 | 44,477 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | A Award deriv | 2026-08-03 | 2026-08-03 | 44,477 | — | $0 | 44,477 | SEC↗ |
| APMD Apnimed, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-03 | 44,477 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | A Award deriv | 2026-08-03 | 2026-08-03 | 51,890 | — | $0 | 51,890 | SEC↗ |
| APMD Apnimed, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-03 | 51,890 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | A Award deriv | 2026-07-30 | 2026-08-03 | 44,477 | — | $0 | 44,477 | SEC↗ |
| APMD Apnimed, Inc. | A Award deriv | 2026-07-30 | 2026-08-03 | 44,477 | — | $0 | 44,477 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2026-06-04 | 2026-06-08 | 24,372 | — | $0 | 24,372 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | D To issuer deriv | 2026-05-14 | 2026-05-14 | 14,684 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | D To issuer deriv | 2026-05-14 | 2026-05-14 | 5,748 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | D To issuer deriv | 2026-05-14 | 2026-05-14 | 37,500 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | D To issuer deriv | 2026-05-14 | 2026-05-14 | 11,199 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | D To issuer deriv | 2026-05-14 | 2026-05-14 | 8,554 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | D To issuer deriv | 2026-05-14 | 2026-05-14 | 7,441 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | D To issuer deriv | 2026-05-14 | 2026-05-14 | 27,600 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | D To issuer | 2026-05-14 | 2026-05-14 | 5,744 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | U Tender | 2026-05-14 | 2026-05-14 | 30,666 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | D To issuer | 2026-05-14 | 2026-05-14 | 3,544 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | D To issuer | 2026-05-14 | 2026-05-14 | 7,961 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | D To issuer | 2026-05-14 | 2026-05-14 | 3,877 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | D To issuer | 2026-05-14 | 2026-05-14 | 3,062 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2026-01-01 | 2026-01-05 | 14,684 | — | $0 | 14,684 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2026-01-01 | 2026-01-05 | 7,961 | — | $0 | 30,666 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2025-06-05 | 2025-06-09 | 25,000 | — | $0 | 25,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2025-01-01 | 2025-01-03 | 11,199 | — | $0 | 11,199 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2025-01-01 | 2025-01-03 | 6,267 | — | $0 | 22,705 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2024-06-06 | 2024-06-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2024-01-01 | 2024-01-02 | 5,748 | $59.86 | $344.1K | 5,748 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2024-01-01 | 2024-01-02 | 3,341 | — | $0 | 16,438 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2023-06-08 | 2023-06-12 | 16,985 | — | $0 | 16,985 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2023-01-01 | 2023-01-04 | 7,441 | — | $0 | 7,441 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2023-01-01 | 2023-01-04 | 3,867 | — | $0 | 13,097 | SEC↗ |
| CVET COVETRUS, INC. | D To issuer deriv | 2022-10-13 | 2022-10-13 | 14,638 | — | $0 | 0 | SEC↗ |
| CVET COVETRUS, INC. | D To issuer | 2022-10-13 | 2022-10-13 | 13,275 | — | $0 | 0 | SEC↗ |
| CVET COVETRUS, INC. | M Exercise deriv | 2022-07-01 | 2022-07-06 | 8,275 | — | $0 | 0 | SEC↗ |
| CVET COVETRUS, INC. | M Exercise | 2022-07-01 | 2022-07-06 | 8,275 | — | $0 | 13,275 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2022-06-09 | 2022-06-10 | 19,000 | — | $0 | 19,000 | SEC↗ |
| CVET COVETRUS, INC. | A Award deriv | 2022-05-11 | 2022-05-13 | 14,638 | — | $0 | 14,638 | SEC↗ |
| GLS GELESIS HOLDINGS, INC. | A Award | 2022-05-06 | 2022-05-09 | 53,832 | — | $0 | 53,832 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2022-01-06 | 2022-01-10 | 8,400 | — | $0 | 8,400 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | P Buy | 2022-01-06 | 2022-01-10 | 3,947 | $19.00 | $75.0K | 3,947 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2022-01-01 | 2022-01-04 | 8,554 | — | $0 | 8,554 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2022-01-01 | 2022-01-04 | 4,230 | — | $0 | 9,230 | SEC↗ |
| CVET COVETRUS, INC. | P Buy | 2021-08-10 | 2021-08-11 | 5,000 | $23.24 | $116.2K | 5,000 | SEC↗ |
| CVET COVETRUS, INC. | A Award deriv | 2021-07-01 | 2021-07-06 | 8,275 | — | $0 | 8,275 | SEC↗ |
| APLS | A Award deriv | 2021-01-01 | 2021-01-04 | 27,600 | — | $0 | 27,600 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS, INC. | D To issuer deriv | 2020-11-16 | 2020-11-17 | 6,000 | — | $0 | 0 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS, INC. | D To issuer deriv | 2020-11-16 | 2020-11-17 | 21,289 | — | $0 | 0 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS, INC. | D To issuer deriv | 2020-11-16 | 2020-11-17 | 9,452 | — | $0 | 0 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS, INC. | D To issuer | 2020-11-16 | 2020-11-17 | 14,676 | — | $0 | 0 | SEC↗ |
| TORC resTORbio, Inc. | A Award deriv | 2020-06-03 | 2020-06-05 | 14,414 | — | $0 | 14,414 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS, INC. | A Award deriv | 2020-06-02 | 2020-06-04 | 21,289 | — | $0 | 21,289 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS, INC. | A Award | 2020-06-02 | 2020-06-04 | 10,269 | — | $0 | 14,676 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | P Buy | 2020-05-08 | 2020-05-12 | 5,000 | $31.81 | $159.1K | 5,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2020-04-02 | 2020-04-06 | 37,500 | — | $0 | 37,500 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS, INC. | A Award deriv | 2019-10-08 | 2019-10-10 | 9,452 | — | $0 | 9,452 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS, INC. | A Award deriv | 2019-10-08 | 2019-10-10 | 6,000 | — | $0 | 6,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS, INC. | A Award | 2019-10-08 | 2019-10-10 | 4,407 | — | $0 | 4,407 | SEC↗ |
| TORC resTORbio, Inc. | A Award deriv | 2019-05-08 | 2019-05-09 | 14,414 | — | $0 | 14,414 | SEC↗ |